Immediate-type hypersensitivity reaction to levothyroxine and desensitization. 2008

Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D006981 Hyperthyroxinemia Abnormally elevated THYROXINE level in the BLOOD. Hyperthyroxinemias
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3
D014581 Urticaria A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. Hives,Urticarial Wheals,Urticarial Wheal,Urticarias,Wheal, Urticarial,Wheals, Urticarial

Related Publications

Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
July 2021, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
March 2018, European annals of allergy and clinical immunology,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
January 1993, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
July 2022, Journal of hepatology,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
November 2022, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
September 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
January 2009, Journal of investigational allergology & clinical immunology,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
September 2018, Therapie,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
February 2022, Federal practitioner : for the health care professionals of the VA, DoD, and PHS,
Anna Sala, and Moises Labrador-Horrillo, and Mar Guilarte, and Olga Luengo, and Maria Rueda, and Victoria Cardona
July 1994, Arthritis and rheumatism,
Copied contents to your clipboard!